Allgen Pharmaceuticals B.V.

What Allgen Pharmaceuticals B.V. does

Allgen Pharmaceuticals B.V. is a legal entity registered in the Netherlands, as indicated by its "B.V." (Besloten Vennootschap, the Dutch private limited company form) suffix and the .nl country-code top-level domain of its corporate web address (allgen.nl). The company's name — "Allgen Pharmaceuticals" — linguistically suggests an orientation toward generic pharmaceuticals, a common positioning among mid-sized Dutch and European pharmaceutical firms, but this interpretation is inferential and not confirmed by any retrieved source content.

No verifiable operational details could be extracted from the available data. The company's primary website (allgen.nl) was inaccessible during data collection, returning a Cloudflare-style human-verification/loader page rather than substantive corporate information. Consequently, no products, therapeutic areas, pipeline assets, manufacturing capabilities, technology stack, regulatory approvals, customers, distributors, revenue model, pricing mechanics, headcount, geographic footprint, founding date, or leadership team details could be confirmed. All structured fields in the source dataset — company history, value proposition, customer segments, partnerships, patents, awards, funding rounds, and management team — were returned empty or marked as unavailable.

The ownership structure is similarly unverified: no parent company, investor, or founder information was disclosed in accessible sources. The company may exist as a registered Dutch legal entity without active commercial operations, as a small specialty distributor or repackager, or as a holding entity for pharmaceutical assets — but none of these characterizations can be confirmed from the data on hand. This profile should be treated as a data-thin entity pending primary source verification, and any downstream investment thesis built on this company would require direct company outreach or registry-level due diligence (e.g., Dutch KVK/Kamer van Koophandel filings) to substantiate basic facts.

Name

Allgen Pharmaceuticals B.V.

Website

https://allgen.nl

Company type

Private

Headcount range

1–10 employees

Short description

Allgen Pharmaceuticals B.V. is a Dutch-registered pharmaceutical entity whose actual product portfolio, customer base, and operational status could not be verified, as its primary website (allgen.nl) was inaccessible during data collection.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIABAA

Small-Molecule Generics (Branded/Unbranded)

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAIABAH

Generic Finished Dosage Form (FDF) Manufacturing

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

Keywords

• Pharmaceutical products
• Drug manufacturing
• Medicinal products
• Pharmaceutical wholesale
• Generic pharmaceuticals

Headquarters

HQ country

Netherlands

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

Allgen Pharmaceuticals B.V. is a Netherlands-based pharmaceutical company, as indicated by its Dutch B.V. (Besloten Vennootschap) legal structure and allgen.nl domain. The company operates within the pharmaceutical sector; however, specific product portfolio, therapeutic categories, and detailed service offerings were not documented in the available source data, as the company website displayed only a verification/loading page.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Polpharma: Largest Polish pharmaceutical manufacturer and a major European generics producer. Comparable as a regional European generic player with broad portfolio depth.
• Teva Pharmaceutical Industries: The world's largest generic medicines manufacturer with a broad small-molecule generics portfolio. Comparable to Allgen if the latter targets the generic drug segment, though Teva operates at vastly greater scale and global reach.
• Viatris: Global pharmaceutical company formed through the Mylan-Upjohn merger with a substantial generics footprint, including significant European operations. Comparable as a broad incumbent in the generic medicines space.
• Stada Arzneimittel: German-headquartered European generics and specialty pharmaceutical company. Relevant comparable for a European BV-structured generics entity, particularly in terms of regional market positioning.
• Krka: Slovenian generic pharmaceutical manufacturer with strong Central and Eastern European presence. Comparable as a regional European generic manufacturer with vertically integrated production.
• Sandoz: Novartis's generics and biosimilars division, headquartered in Europe with a strong generic small-molecule portfolio. A relevant comparable for a European generic-focused pharmaceutical entity like Allgen.
• Aurobindo Pharma: Indian-headquartered global generic pharmaceutical manufacturer with significant European sales. Comparable as a generics supplier serving European markets at competitive price points.

Regional players

• Centrient Pharmaceuticals: Dutch-headquartered pharmaceutical company producing generic active pharmaceutical ingredients (APIs) and finished dosage forms. Most directly comparable in terms of Dutch domicile and generic pharmaceutical focus.

Market position

Strengths2 records

Weaknesses3 records

Key risks3 records

Key highlights2 records

Customer concentration

• LinkedInlinkedin.com/company/allgen-pharmaceuticals-b.v.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allgen Pharmaceuticals B.V.